Long-Term Breast Cancer Risk in Hodgkin Lymphoma Survivors Treated With Doxorubicin
(MedPage Today) -- A common chemotherapy drug used to treat Hodgkin lymphoma conferred a significantly increased risk of breast cancer among women treated during adolescence and adulthood, a large retrospective study showed.
Women who received...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Hematology | Lymphoma | Study | Women